Opus Genetics, Inc (IRD)
NCM · Common · CUSIP 67577R102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IRD and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
67577R102 (prev. 761640309 )
Market Cap
Micro Cap
Previous Symbol
OCUP (changed 10/22/2024)
Previous Name
Ocuphire Pharma, Inc.
Business: Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire’s pipeline currently includes two small-molecule product candidates targeting front and back of the eye indications.

Company Contact

CEO
George Magrath
CFO
Nirav Hhaveri
Headquarters
8 Davis Drive, Suite 220, Durham, NC 27709
Phone
984-884-6030
Investor Relations
LifeSci Advisors · 646-889-1200 · cdavis@lifesciadvisors.com
General Email
ir@opusgtx.com
SEC EDGAR Filings
View filings »